In late 2020, Kentucky Governor Andy Beshear loosened Medicaid restrictions to expand substance abuse treatment during the COVID-19 pandemic, aiming to prevent overdose deaths amid isolation.
The Pandemic Pivot and the Unprecedented Expansion of Addiction Services
By the end of 2020, Kentucky faced dual public health emergencies: the COVID-19 pandemic and some of the highest drug overdose death rates in the nation. Operating on the belief that addiction breeds in isolation, Governor Andy Beshear moved to make substance abuse treatment radically easier to access. Kentucky joined more than 40 other states by lifting key restrictions on Medicaid, allowing recovery centers to offer expensive residential treatments without seeking prior approval from state Medicaid insurers.
As the pandemic waned, other states reinstated their Medicaid prior authorization requirements, but Kentucky maintained its loosened rules. By 2023, providers offered more than 1,100 spots for long-term residential treatment, establishing a state record and more slots per capita than anywhere else in the country. However, state spending skyrocketed alongside the treatment capacity, reaching an unprecedented $2.3 billion for behavioral health and addiction treatment by fiscal year 2024, according to Kentucky Medicaid Commissioner Lisa Lee.
Warnings Ignored and the Rise of Lucrative Billing Exploits
As state expenditures mounted, health industry experts issued a wave of warnings. Insurers, actuaries, and local officials cautioned that the relaxed oversight was enabling unscrupulous operators to bill heavily for subpar care and low-level services that failed to drive better health outcomes. According to ProPublica and the Lexington Herald-Leader, Addiction Recovery Care (ARC)—Kentucky’s largest drug treatment provider—became the primary beneficiary of these loosened controls, collecting massive sums of state funds between 2019 and 2025.
State data revealed that behavioral health providers were paid more than $147 million for peer support services across 2023 and 2024. During that same window, Medicaid payments for psychoeducation surged from $40.4 million to over $168 million, with the vast majority of those funds flowing to ARC. Medicaid insurers warned lawmakers that Kentucky stood out as an outlier in permitting separate billing for psychoeducation, making the service a prime target for overutilization.
Despite receiving warning letters throughout 2023 and 2024 from organizations like the Kentucky Association of Health Plans, as well as direct appeals from local leaders such as Somerset Mayor Alan Keck, the Beshear administration resisted immediate policy reversals. Governor Beshear defended his administration’s position, insisting that the priority was keeping people alive. As the governor stated in an interview with ProPublica, If we’d gone back in time too early and changed things too drastically, how many more people would have died that we’ve saved? With four straight years of drug overdose decreases, they can throw blame at me.
Federal Indictments, Whistleblower Lawsuits, and Enforcement Actions
The lax regulatory environment ultimately collided with aggressive federal enforcement. A two-year FBI investigation culminated this week when the Department of Justice announced a $16 million settlement with Addiction Recovery Care to resolve allegations of Medicaid fraud stemming from a 2023 whistleblower lawsuit filed by three former employees. The allegations stated that the company directed employees to falsely bill Medicaid for peer support services.
Compounding the corporate crisis, the Department of Justice indicted ARC founder Tim Robinson on charges of wire fraud and money laundering connected to a separate alleged scheme targeting multiple lenders. Robinson has pleaded not guilty to those charges. As legal and financial pressures mounted, ARC was forced to shutter most of its facilities, triggering a staggering 56% decrease in long-term residential treatment beds across the state of Kentucky.
Academic researchers point out that Kentucky’s decline in overdose deaths mirrors broader national trends. Studies published by public health researchers indicate that falling fatality rates across multiple states—including Tennessee and West Virginia, which maintained strict Medicaid rules—were largely driven by reduced opioid prescribing rates, the widespread distribution of the reversal drug naloxone, and a lower concentration of fentanyl in the illicit drug supply, rather than specific low-level behavioral health billing practices.
Legislative Rebuke and the Ongoing Battle Over Oversight
By 2025, Kentucky’s Republican-controlled General Assembly concluded that administrative inaction had crossed a line. Lawmakers passed legislation stripping the governor of his unilateral authority over Medicaid program rules and mandating the reinstatement of prior authorization guardrails for treatment centers. Although Governor Beshear vetoed the bill, arguing that it would create harmful healthcare barriers for vulnerable residents, the legislature successfully overrode his veto.
State Senator Chris McDaniel sharply criticized the administration’s handling of the crisis during legislative hearings, stating that the executive branch had to be one of three things: willfully ignorant, derelict in their duties, or complicit. It was too much money in one space for them not to have known better.
While the Office of Attorney General noted that Medicaid fraud in addiction treatment remains a primary area of concern, the long-term fallout leaves Kentucky grappling with a fractured recovery infrastructure. The tension between rapidly expanding access to care during an unprecedented health crisis and maintaining the fiscal accountability necessary to prevent systemic fraud highlights a difficult lesson for policymakers managing public health emergency powers.
